Back
ESC Professional Premium Access

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Session: Chronic heart failure and atrial fibrillation
Topic: Pharmacotherapy
Speaker: Doctor M. Tokutome (Fukuoka, JP)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Masaki Tokutome

Fukuoka Red Cross Hospital, Fukuoka (Japan)
0 follower

6 more presentations in this session

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Speaker: Ms E. Angeli (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Speaker: Ms T. Gonzalez Ferrero (Santiago de Compostela, ES)

Access
Abstract
Slides
Like
Thumbnail

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Speaker: Doctor M. Iguchi (Kyoto, JP) Doctor M. Akao (Kyoto, JP)

Access
Abstract
Slides
Like
Thumbnail

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)

Access
Abstract
Slides
Like
Thumbnail

Survival among people with heart failure and atrial fibrillation; a population cohort study

Speaker: Doctor N. Jones (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure and atrial fibrillation

Speakers: Doctor M. Tokutome, Ms E. Angeli, Ms T. Gonzalez Ferrero, Doctor M. Iguchi, Doctor M. Akao...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources